| Mepha Pharma AG - Lecapon-Mepha 150 mg / 37.5 mg / 200 mg, Lactab | | 65283 | | 05 | | Lecapon-Mepha 150 mg / 37.5 mg / 200 mg | | Lactab | | N04BA03 | | Levodopa, decarboxylase inhibitor and COMT inhibitor | | 25.03.2015 | | |
| | Composition | | levodopum 150.0 mg, carbidopum 37.5 mg, entacaponum 200.0 mg, cellulosum microcristallinum, lactosum 80.0 mg, hydroxypropylcellulosum substitutum humile, povidonum, silica colloidalis anhydrica, magnesii stearas, Überzug: E 171, hypromellosum, glycerolum, polysorbatum 80, E 172 (rubrum), E 122 2.88 mg, magnesii stearas pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Carbidopa | 37.5 mg | | Entacapone | 200 mg | | Levodopa | 150 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Carbidopa | 37.5 mg | | Entacapone | 200 mg | | Levodopa | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | E 122 | 2.88 mg | color. | | E 171 | | Überzug | | E 172 | | color. | | Glycerol | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Hypromellosum | | | | Lactosum | 80 mg | | | Magnesii Stearas | | | | Magnesii Stearas pro Compresso Obducto | | | | Polysorbatum 80 | | | | Povidone | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 009 | 30 Comprimé(s) | 20.03 | 38.20 | B | LS | Oui | | 010 | 100 Comprimé(s) | 61.76 | 83.60 | B | LS | Oui |
|
|
